Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers.

Mark C ZobeckJaved KhanRajkumar VenkatramaniM Fatih OkcuMichael E Scheurer Philip J Lupo

Published in: medRxiv : the preprint server for health sciences (2024)

Incorporating molecular markers into RMS prognosis models improves prognosis predictions. Individualized prognosis predictions may suggest alternative treatment regimens compared to traditional risk-classification schemas. Improved clinical variables and external validation are required prior to implementing these models into clinical practice.

Keyphrases

clinical practice
deep learning
single molecule
gene expression
quality improvement
copy number
combination therapy
smoking cessation